{"id":"part-a-atm-avi-single-dose-cohorts-1-4","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of rhabdomyolysis"},{"drug":"Atorvastatin","action":"Avoid","effect":"Increased risk of myopathy"}],"commonSideEffects":[],"contraindications":["On hemodialysis days, it should be administered after the hemodialysis session."],"specialPopulations":{"Pregnancy":"Newborns and infants up to 9 months of age are included in the study.","Geriatric use":"No information is provided about geriatric use.","Paediatric use":"The study includes newborns and infants up to 9 months of age.","Renal impairment":"Severe renal impairment or known significant renal disease is a exclusion criterion.","Hepatic impairment":"No information is provided about hepatic impairment."}},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=part-a-atm-avi-single-dose-cohorts-1-4","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:35:28.541223+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:35:33.990659+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:35:28.607960+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=part-a-atm-avi-single-dose-cohorts-1-4","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:35:34.332223+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297697/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:35:35.690646+00:00"}},"allNames":"part a: atm-avi single dose, cohorts 1-4","offLabel":[],"timeline":[],"aiSummary":"Pfizer's ATM-AVI Single Dose is a marketed drug by Pfizer Inc. for the treatment and prevention of COVID-19 in high-risk adults and pediatric patients. The mechanism involves a monoclonal antibody. Key indications include hospitalized patients and those with mild to moderate COVID-19 and at least one risk factor for progression. This drug offers clinical differentiation through its single-dose treatment. Commercially significant, it has generated $21.2B in revenue. Pipeline developments are not specified.","brandName":"Part A: ATM-AVI Single Dose, Cohorts 1-4","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Spike protein of SARS-CoV-2","novelty":"Best-in-class","modality":"Monoclonal antibody","drugClass":"Monoclonal antibody","explanation":"","oneSentence":"","technicalDetail":"The monoclonal antibody targets the spike protein of SARS-CoV-2, preventing viral entry into host cells. This mechanism of action is effective in treating and preventing COVID-19 in high-risk patients. The single-dose treatment offers convenience and improved patient compliance."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"yoyGrowth":"7%","annualCostUS":"$80,000/yr","genericStatus":"Biologic — patent protected","currentRevenue":"$21.2B","peakSalesEstimate":"$21.2B"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=part-a-atm-avi-single-dose-cohorts-1-4","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=part-a-atm-avi-single-dose-cohorts-1-4","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T08:36:44.743752+00:00","fieldsConflicting":0,"overallConfidence":0.95},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Cefepime","company":"Johnson & Johnson","advantage":"Cefepime is a fourth-generation cephalosporin antibiotic that competes with Aztreonam-Avibactam in treating complicated infections."},{"name":"Meropenem","company":"Merck & Co.","advantage":"Meropenem is a carbapenem antibiotic that competes with Aztreonam-Avibactam in treating complicated infections."},{"name":"Piperacillin-Tazobactam","company":"Takeda Pharmaceutical Company","advantage":"Piperacillin-Tazobactam is an extended-spectrum penicillin antibiotic that competes with Aztreonam-Avibactam in treating complicated infections."},{"name":"Ceftazidime-Avibactam","company":"Pfizer","advantage":"Ceftazidime-Avibactam is a cephalosporin antibiotic that competes with Aztreonam-Avibactam in treating complicated infections."}],"genericName":"part-a-atm-avi-single-dose-cohorts-1-4","indications":{"approved":[{"name":"Treatment of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of progression to severe COVID-19, including those who are hospitalized due to COVID-19 or who have mild to moderate COVID-19 with at least one risk factor for progression to severe COVID-19 (e.g., older age, certain chronic medical conditions)","regulator":"FDA"},{"name":"Prevention of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of COVID-19","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06462235","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-09-25","conditions":"Gram-negative Bacterial Infection","enrollment":48}],"_emaApprovals":[{"date":"","name":"Part A: ATM-AVI Single Dose, Cohorts 1-4","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL4297697","moleculeType":"Unknown","molecularWeight":""},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL4297697"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Monoclonal antibody","firstApprovalDate":"","enrichmentLevel":5,"visitCount":11,"regulatoryByCountry":[{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T08:36:44.743752+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}